RESUMEN
Naturally occurring anticarcinogens, such as vitamins C and E, and the microelement selenium were found to inhibit the induction of benzo[a]pyrene-induced malignant tumors in Wistar rats to various extends. The antineoplastic effect of the tested anticarcinogens is gradually increased according to the number of inhibitors selected. To date the maximum action against malignancy is manifested by use of the above three inhibitors. In the group of rats receiving vitamins C, E and selenium, the prolongation of life induced by adding more than one anticarcinogen to the treatment regime reached, and in some cases surpassed, the normal life expectancy of the rats. It is expected that by adding even more anticarcinogens, the antineoplastic potency (Ap) of the inhibitors will be further improved. These results encouraged us to conduct a clinical trial in terminal human cancer cases, in conjunction with the usual treatments of surgery or chemotherapy and irradiation.
Asunto(s)
Antineoplásicos/farmacología , Ácido Ascórbico/farmacología , Benzo(a)pireno/antagonistas & inhibidores , Neoplasias Experimentales/prevención & control , Selenio/farmacología , Vitamina E/farmacología , Animales , Ensayos de Selección de Medicamentos Antitumorales , Sinergismo Farmacológico , Femenino , Neoplasias Experimentales/inducido químicamente , Neoplasias Experimentales/mortalidad , Ratas , Ratas WistarRESUMEN
Evidence is presented that cardiolipin, a naturally occurring phospholipid, inhibits the aggregatory effect of platelet-activating factor (paf) on rabbit platelets in vitro. Bovine heart cardiolipin was shown to inhibit the aggregation of washed rabbit platelets induced by 1 x 10(-10) M and 2 x 10(-10) M paf with IC50 values (doses for half-maximal inhibition) of 8.4 +/- 0.8 x 10(-7) M and 2.6 +/- 0.6 x 10(-6) M, respectively. Phosphonocardiolipin was also able to inhibit platelet aggregation induced by 1 x 10(-10) M paf with an IC50 value of 3 +/- 1 x 10(-7) M. Both compounds, in concentrations up to 1 x 10(-5) M, were unable to aggregate washed rabbit platelets and failed to inhibit the aggregation induced by 0.9 and 1.8 microM adenosine diphosphate or 0.2-1.0 microM arachidonic acid. By contrast, the acetylated derivative of cardiolipin exerted an aggregatory effect on aspirin-treated rabbit platelets in the presence of creatine phosphate/creatine phosphokinase. This aggregation was inhibited by the specific paf antagonists BN 52021 and WEB 2086. Also, platelets treated with acetyl-cardiolipin were insensitive to the aggregatory effect of paf. Phosphatidic acid, phosphatidylglycerol, bis(dipalmitoylglycero)phosphate and their phosphono analogues were totally inactive. Similar data were obtained when platelet-rich plasma was used instead of washed rabbit platelets. Our results support the hypothesis that the effect of cardiolipin is mediated through specific paf receptors that act on the rabbit platelet membrane.
Asunto(s)
Cardiolipinas/farmacología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Activación Plaquetaria/efectos de los fármacos , Animales , Bovinos , Técnicas In Vitro , Masculino , Estructura Molecular , Fosfatidilgliceroles/farmacología , ConejosRESUMEN
The effect of high doses vitamin B12 on the nucleus-bearing erythrocytes in the peripheral blood of the frog, chicken and trout has been investigated. The i.p. and i.m. injection of 5 mg B12/animal, caused the separation of the nucleus from the cytoplasm of the erythrocytes to various degrees. The most pronounced effect was observed in trouts, where 75% of the erythrocytes lost their cytoplasm. Frog and chicken were less susceptible to the denucleating effect of B12. About 10-15% of the frog and chicken erythrocytes lost their cytoplasm 7-8 weeks after the B12 injection.